Amneal Pharmaceuticals (AMRX) Raw Materials (2017 - 2020)

Amneal Pharmaceuticals has reported Raw Materials for 4 years, with the latest figure at $162.7 million in Q1 2020.

• On a quarterly basis, Raw Materials changed N/A year-over-year to $162.7 million in Q1 2020; TTM through Mar 2020 was $162.7 million, a N/A change from a year earlier, with the FY2019 full-year figure at $172.2 million, down 5.23% from the prior year.
• Raw Materials was $162.7 million for Q1 2020 at Amneal Pharmaceuticals, down from $172.2 million in the prior quarter.
• The five-year high for Raw Materials was $205.1 million in Q3 2018, with the low at $140.1 million in Q4 2017.
• Average Raw Materials over 4 years is $178.4 million, with a median of $180.9 million recorded in 2018.
• The sharpest annual moves came in 2018 and 2019: Raw Materials climbed 29.71% in 2018, then fell 11.13% in 2019.
• Over 4 years, Raw Materials stood at $140.1 million in 2017, then gained by 29.71% to $181.7 million in 2018, then declined by 5.23% to $172.2 million in 2019, then retreated by 5.48% to $162.7 million in 2020.
• The last three Raw Materials figures came in at $162.7 million (Q1 2020), $172.2 million (Q4 2019), and $182.8 million (Q3 2019), per Business Quant data.